ALS and FTD: Where RNA metabolism meets protein quality control
- PMID: 31254610
- DOI: 10.1016/j.semcdb.2019.06.003
ALS and FTD: Where RNA metabolism meets protein quality control
Abstract
Recent genetic and biochemical evidence has improved our understanding of the pathomechanisms that lead to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two devastating neurodegenerative diseases with overlapping symptoms and causes. Impaired RNA metabolism, enhanced aggregation of protein-RNA complexes, aberrant formation of ribonucleoprotein (RNP) granules and dysfunctional protein clearance via autophagy are emerging as crucial events in ALS/FTD pathogenesis. Importantly, these processes interact at the molecular level, converging on a common pathogenic cascade. In this review, we summarize key principles underlying ALS and FTD, and we discuss how mutations in genes involved in RNA metabolism, protein quality control and protein degradation meet mechanistically to impair the functionality and dynamics of RNP granules, and how this leads to cellular toxicity and death. Finally, we describe recent advances in understanding signaling pathways that become dysfunctional in ALS/FTD, partly due to altered RNP granule dynamics, but also with stress granule-independent mechanisms and, thus could be promising targets for future therapeutic intervention.
Keywords: Amyotrophic lateral sclerosis; Frontotemporal dementia; Phase separation; Protein aggregation; Protein quality control; Stress granules.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.Trends Mol Med. 2016 Sep;22(9):769-783. doi: 10.1016/j.molmed.2016.07.005. Epub 2016 Aug 4. Trends Mol Med. 2016. PMID: 27498188 Review.
-
Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules.RNA. 2022 Jan;28(1):97-113. doi: 10.1261/rna.079001.121. Epub 2021 Oct 27. RNA. 2022. PMID: 34706979 Free PMC article. Review.
-
RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration.Sci Transl Med. 2017 Nov 8;9(415):eaah5436. doi: 10.1126/scitranslmed.aah5436. Sci Transl Med. 2017. PMID: 29118263 Review.
-
Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.Neurobiol Dis. 2020 Feb;134:104639. doi: 10.1016/j.nbd.2019.104639. Epub 2019 Oct 15. Neurobiol Dis. 2020. PMID: 31626953 Review.
-
Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.Brain Res. 2018 Aug 15;1693(Pt A):98-108. doi: 10.1016/j.brainres.2018.02.011. Epub 2018 Feb 14. Brain Res. 2018. PMID: 29453960 Free PMC article. Review.
Cited by
-
The Impact of ALS-Associated Genes hnRNPA1, MATR3, VCP and UBQLN2 on the Severity of TDP-43 Aggregation.Cells. 2020 Jul 28;9(8):1791. doi: 10.3390/cells9081791. Cells. 2020. PMID: 32731393 Free PMC article.
-
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial.Brain Commun. 2024 Sep 5;6(5):fcae304. doi: 10.1093/braincomms/fcae304. eCollection 2024. Brain Commun. 2024. PMID: 39291166 Free PMC article. Clinical Trial.
-
Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death.Cell Cycle. 2021 Apr;20(7):631-646. doi: 10.1080/15384101.2021.1886661. Epub 2021 Mar 15. Cell Cycle. 2021. PMID: 33722167 Free PMC article. Review.
-
Upper and Lower Motor Neurons and the Skeletal Muscle: Implication for Amyotrophic Lateral Sclerosis (ALS).Adv Anat Embryol Cell Biol. 2023;236:111-129. doi: 10.1007/978-3-031-38215-4_5. Adv Anat Embryol Cell Biol. 2023. PMID: 37955773
-
Aberrant Phase Separation of FUS Leads to Lysosome Sequestering and Acidification.Front Cell Dev Biol. 2021 Oct 22;9:716919. doi: 10.3389/fcell.2021.716919. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34746121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
